RxDoctor Payments Data

Pamela Thompson, DO

Family Medicine · Holt, MINPI 1740244169

Payments from drug & device makers

$393in general payments, 2019–2025

Across 25 payments — averaging $15.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$90
  • Pfizer$66
  • Lilly USA, LLC$58
  • Amgen$41
  • GSK$35
  • Novo Nordisk$34
  • plus $69 from 5 others

What the payments were for

  • Food & beverage$393100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$393 in reported general payments places this provider in the 55th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$30,697
Medicare patients
100
Services billed
396

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin70$111,040
TrulicityDulaglutide52$81,658
RybelsusSemaglutide34$66,300
Trelegy ElliptaFluticasone/Umeclidin/Vilanter31$52,173
EliquisApixaban47$46,813
XareltoRivaroxaban40$41,540
MounjaroTirzepatide22$35,628
OzempicSemaglutide22$34,680
TradjentaLinagliptin25$31,869
ProliaDenosumab17$27,795
AbrysvoRsv Vacc, Pref A And Pref B/Pf78$25,046
VraylarCariprazine Hcl11$23,568
JanuviaSitagliptin Phosphate25$22,950
Spiriva RespimatTiotropium Bromide27$21,508
MyrbetriqMirabegron20$17,443

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$58$117,28674 claims
Novo NordiskRybelsus, Ozempic$34$100,97956 claims
GSKTrelegy Ellipta, Shingrix, Anoro Ellipta, Breo Ellipta$35$80,676108 claims
PfizerEliquis, Abrysvo$66$71,859125 claims
AmgenProlia$41$27,79517 claims
AbbVieVraylar$90$23,56811 claims
Astellas Pharma US IncMyrbetriq$12$17,44320 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Holt

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →